Polypeptides Having Beta-1,3-Galactanase Activity and Polynucleotides Encoding Same

US2016174589A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016174589-A1
Application numberUS-201414909579-A
CountryUS
Kind codeA1
Filing dateAug 15, 2014
Priority dateAug 15, 2013
Publication dateJun 23, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to polypeptides having beta-1,3-galactanase activity and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.

First claim

Opening claim text (preview).

1 . A polypeptide having beta-1,3-galactanase activity, selected from the group consisting of: (a) a polypeptide having at least 65% sequence identity to the mature polypeptide of SEQ ID NO: 2; (b) a polypeptide encoded by a polynucleotide that hybridizes under low stringency conditions with the mature polypeptide coding sequence of SEQ ID NO: 1 or the full-length complement hereof; (c) a polypeptide encoded by a polynucleotide having at least 65% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 1; (d) a variant of the mature polypeptide of SEQ ID NO: 2 comprising a substitution, deletion, and/or insertion at one or more positions; and (e) a fragment of the polypeptide of (a), (b), (c), or (d) that has beta-1,3-galactanase activity. 2 . The polypeptide of claim 1 , which is an isolated polypeptide. 3 . The polypeptide of claim 1 , having at least 65% sequence identity to the mature polypeptide of SEQ ID NO: 2. 4 . The polypeptide of claim 1 , which is encoded by a polynucleotide that hybridizes under low stringency conditions, low-medium stringency conditions, medium stringency conditions, medium-high stringency conditions, high stringency conditions, or very high stringency conditions with the mature polypeptide coding sequence of SEQ ID NO: 1 or the full-length complement hereof. 5 . The polypeptide of claim 1 , which is encoded by a polynucleotide having at least 65% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 1. 6 . The polypeptide of claim 1 , comprising or consisting of SEQ ID NO: 2 or the mature polypeptide of SEQ ID NO: 2. 7 . The polypeptide of claim 1 , wherein the mature polypeptide is amino acids 21 to 256 of SEQ ID NO: 2. 8 . A composition comprising the polypeptide of claim 1 . 9 . (canceled) 10 . An isolated polynucleotide encoding the polypeptide of claim 1 . 11 . A nucleic acid construct or expression vector comprising the polynucleotide of claim 10 operably linked to one or more control sequences that direct the production of the polypeptide in an expression host. 12 . A recombinant host cell comprising the polynucleotide of claim 10 operably linked to one or more control sequences that direct the production of the polypeptide. 13 . A method of producing a polypeptide having beta-1,3-galactanase activity, comprising cultivating the host cell of claim 12 under conditions conducive for production of the polypeptide. 14 . The method of claim 13 , further comprising recovering the polypeptide. 15 . A whole broth formulation or cell culture composition comprising a polypeptide of claim 1 . 16 . A method or producing a coffee extract, comprising the steps: a. providing roast and ground coffee beans; b. adding to said coffee beans water and a polypeptide of claim 1 ; c. incubating to make an aqueous coffee extract; and d. separating the coffee extract from the extracted coffee beans.

Assignees

Inventors

Classifications

  • A23F5/246Primary

    Addition of, or treatment with, enzymes or microorganisms (A23F5/163 and A23F5/204 take precedence) · CPC title

  • acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81) · CPC title

  • Galactan endo-beta-1,3-galactanase (3.2.1.181) · CPC title

  • Drying or concentrating coffee extract {(A23F5/246 takes precedence)} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016174589A1 cover?
The present invention relates to polypeptides having beta-1,3-galactanase activity and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
Who is the assignee on this patent?
Novozymes As
What technology area does this patent fall under?
Primary CPC classification A23F5/246. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Jun 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).